ED-B fibronectin (ED-B) can be targeted using a novel single chain antibody conjugate and is associated with macrophage accumulation in atherosclerotic lesions.

  • Dietrich Thore
  • Christin Perlitz
  • Kai Licha
  • Philipp Stawowy
  • Kirstin Atrott
  • Michael Tachezy
  • Heike Meyborg
  • Carolin Stocker
  • Michael Gräfe
  • Eckart Fleck
  • Michael Schirner
  • Kristof Graf

Abstract

It has been shown that ED-B fibronectin (ED-B) is a potential target for plaque imaging. The aim of this study was to test a novel modified single chain anti-ED-B antibody (scFv) conjugated for near infrared fluorescence imaging (NIRF) with tetrasulfonated carbocyanine-maleimide (TSC-scFv) and to examine the association of ED-B with the presence of macrophages in a murine model of atherosclerosis. Expression of ED-B was observed in plaque areas in apolipoprotein E-deficient (apoE(-/-)) mice which increased with age and plaque load. Robust imaging was possible after explantation of the aorta and demonstrated a strong NIRF signal intensity in focal aortic and brachiocephalic plaque lesions, whereas no signals were found in undiseased areas. Plaque lesion ED-B was expressed by smooth muscle cell and was closely associated to macrophage infiltrates. Although not expressed by the same cell type, there was a significant correlation (p

Bibliografische Daten

OriginalspracheDeutsch
Aufsatznummer4
ISSN0300-8428
StatusVeröffentlicht - 2007
pubmed 17468934